All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Wegovy Weight Loss: Results Timeline & What to Expect

Wegovy weight loss results timeline from STEP clinical trials. See week-by-week data, average pounds lost by dosage, and what to realistically expect.

By FormBlends Editorial Research||
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Wegovy works gradually over many months, with the dose climbing in steps before reaching the level that drives the most weight loss. Here is what the timeline typically looks like.

See your GLP-1 options in about 2 minutes. Free and private. See my options →

Quick answer

Wegovy (semaglutide 2.4 mg) is titrated over roughly 16 to 20 weeks, so the first months involve lower doses and modest weight loss before reaching the full maintenance dose. In the STEP 1 trial, average weight loss was about 15 percent of body weight over 68 weeks. Most people notice steady loss building through the first several months, continuing through much of the first year before plateauing. Results vary by person, and the full effect unfolds over more than a year, not a few weeks.

How long does Wegovy take to work?

Wegovy starts at a low dose (0.25 mg) and increases every four weeks up to the 2.4 mg maintenance dose, a process that takes about 16 to 20 weeks. Because of this slow ramp, the early weeks are about adjusting and limiting side effects, not maximizing weight loss.

Appetite suppression often begins within the first weeks, but the larger weight changes typically come once you reach higher doses. The realistic frame is months, with the biggest cumulative loss accruing over the first year.

Wegovy weight-loss timeline: first month and beyond

The pattern follows the titration schedule and the trial data.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →
  • First month (0.25 mg start): Appetite usually begins to decrease. Weight loss is modest. Mild nausea is common early.
  • Months 2 to 4 (dose increasing): As the dose steps up, appetite suppression strengthens and weight loss becomes more noticeable.
  • Months 4 to 6 (reaching 2.4 mg): Many people see their steadiest loss after reaching the maintenance dose.
  • Months 6 to 12: Loss continues for many, often slowing gradually, building toward trial-level totals.
  • Beyond 12 months: Weight loss tends to plateau as the body reaches a new set point, and maintenance becomes the focus.

What the clinical trials showed

In STEP 1, adults with obesity (without diabetes) taking semaglutide 2.4 mg lost an average of about 14.9 percent of body weight over 68 weeks, versus about 2.4 percent on placebo. That average masks a wide range; some people lost much more and some less. The 68-week timeline is the clearest signal that Wegovy's full effect is a long game.

What about the first-month expectations?

Many people hope for dramatic first-month results, but the starting dose is intentionally low. Expect appetite changes and modest weight loss in month one rather than a large drop. This is by design, to ease the body in and reduce nausea. Judging the medication by the first few weeks undersells what it does over months.

Comparison: Wegovy timeline by phase

PhaseDoseTypical weight loss
Month 10.25 mg startModest; appetite begins dropping
Months 2 to 4Titrating upMore noticeable loss
Months 4 to 62.4 mg maintenanceOften the steadiest loss
6 to 12 months2.4 mgContinued, gradual loss
12+ months2.4 mgPlateau, maintenance focus

Why weight loss plateaus

A plateau later in the journey is expected. As you lose weight, the body adapts and the rate of loss slows, often signaling you are nearing a new stable weight. This is not a failure of the medication. If a plateau happens early or unexpectedly, your provider may review your dose, diet, and activity. Sustaining the loss becomes the goal once you plateau.

What affects your results?

Dose, diet, activity, consistency, and individual biology all shape the outcome. Wegovy works best alongside reduced calorie intake and regular movement, with enough protein to protect muscle. Missing doses or stopping early interrupts progress, and stopping usually leads to weight regain.

Where FormBlends fits

If you are on or considering Wegovy and want realistic, month-by-month expectations, FormBlends keeps plain-language guides on compounded semaglutide and a provider comparison tool so you can find a program that supports you across the full timeline.

Frequently asked questions

How long does Wegovy take to work for weight loss?

Appetite changes can start in the first weeks, but meaningful loss builds over months as the dose increases, with trial averages measured over 68 weeks.

How much weight will I lose in the first month on Wegovy?

Usually a modest amount, since the starting dose is low (0.25 mg). More noticeable loss follows as the dose climbs.

What is the average weight loss on Wegovy?

About 15 percent of body weight over 68 weeks in STEP 1, on average. Individual results vary.

How long does it take to reach the full Wegovy dose?

About 16 to 20 weeks, titrating from 0.25 mg up to the 2.4 mg maintenance dose.

When does Wegovy weight loss plateau?

Typically later in the first year to 18 months, as the body reaches a new set point.

Why is my first-month loss small?

The dose starts low by design to limit side effects, so the largest loss comes later in the process.

Does Wegovy keep working after a plateau?

It helps maintain your loss. A plateau usually means you are near a new stable weight rather than that the drug stopped working.

What helps maximize Wegovy results?

Reaching the maintenance dose, eating a balanced higher-protein diet, staying active, and being consistent with weekly doses.

Sources

  • New England Journal of Medicine, STEP 1 semaglutide trial: https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
  • Novo Nordisk, Wegovy prescribing information and dosing: https://www.novo-pi.com/wegovy.pdf

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →
Wegovy Weight Loss: Results Timeline & What to Expect custom 2026 header image for GLP-1 Weight Loss
Custom header image for Wegovy Weight Loss: Results Timeline & What to Expect, GLP-1 Weight Loss, and better treatment decision-making.

Research Snapshot

Medication guide
Page type
Medication guide
Page metadata
Page updated
2026-07-03T20:00:00Z
Page metadata
FormBlends official source
Official source
Semaglutide official website
Official source
Wegovy official website
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Page updated: 2026-07-03T20:00:00Z.

Continue with decision-grade research

Compare the options behind this question

These pages separate verified facts, commercial terms, and unresolved claims so you can check the evidence before choosing a provider.

Provider decision path

Use local research to choose a safer review path

Related treatment context

Wegovy Weight Loss: Results Timeline & What to Expect is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

FormBlends Editorial Context

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use FormBlends tools and data

Compare provider prices, explore local access and check calculations using FormBlends tools and data.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Next Best Reads

FormBlends for iPhone

Shot days, doses and progress in one place

The free FormBlends iPhone app tracks GLP-1 doses, shot-day reminders, weight trends, meals and private progress photos.

Free Tools

Calculators to support your weight loss journey.